01 / Vendor Profile
INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC. Federal Contracts and Awards
UEI Z82HHPY83MC7 · CAGE 6Y2X5
Federal contract activity attributed to this vendor identity across FY 2020–FY 2026. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2020–FY 2026.
Across FY 2020–FY 2026, FPDS records attribute $1.53M in net contract obligations to INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC. across 12 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC. contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$436.1K
FY 2026ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2022 | $582.8K | 2 | 1 | — |
| FY 2023 | $263.0K | 2 | 1 | −54.9% |
| FY 2024 | $248.6K | 3 | 1 | −5.5% |
| FY 2025 | $0 | 3 | 1 | −100.0% |
| FY 2026 | $436.1K | 2 | 2 | — |
04 / Federal Customers
Which federal agencies buy from INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.?
Ranked by net obligations during FY 2020–FY 2026.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7524 | $1.42M | 11 | 92.7% | |
| 7529 | $111.1K | 1 | 7.3% |
05 / Contracting Offices
Which contracting offices buy from INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.?
Ranked by net obligations during FY 2020–FY 2026.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75F401 | FOOD AND DRUG ADMINISTRATION | $1.42M | 11 | 92.7% | |
| 75N930 | NATIONAL INSTITUTES OF HEALTH | $111.1K | 1 | 7.3% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $914.3K | 9 | 2 | 59.7% |
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | $325.0K | 1 | 1 | 21.2% |
| 541720 | RESEARCH AND DEVELOPMENT IN THE SOCIAL SCIENCES AND HUMANITIES | $291.1K | 2 | 1 | 19.0% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
08 / Competition Pattern
How was INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 75N93026F00001 | Sep 25, 2026 | $111.1K | NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH NIAID | 541714 | AN11 |
10 / Interpreting the Profile
How should you evaluate INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC. as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.